April 12, 2023

Surface Transforms: The Future of Carbon Ceramic Brakes

Surface Transforms plc (LON:SCE) is a UK-based company that designs, develops, manufactures, and sells carbon ceramic products for the brakes market in the UK and the..

Nanoco: Investing in the Future of Quantum Dots and Nanoparticles

Nanoco Group plc (LON:NANO), a company listed on the London Stock Exchange, is a market leader in the research, development, licensing, and manufacture of cadmium-free quantum..

Nuformix “tranilast at the heart of NXP002” in treating fibrosis (LON:NXF)

Nuformix plc (LON:NFX) Executive Director Dan Gooding caught up with DirectorsTalk discuss what the NXP002 programme is & its purpose, key findings from the results, and..

Anglo American De Beers sees good demand for rough diamonds in cycle 3

Anglo American plc (LON:AAL) has announced the value of rough diamond sales (Global Sightholder Sales and Auctions) for De Beers’ third sales cycle of 2023, amounting..

Saietta advances confidently with US & India contracts (LON:SED)

Saietta Group plc (LON:SED) Executive Chairman Tony Gott caught up with DirectorsTalk to discuss the e-drive units order from AYRO, why the deal is so important,..

Unite Students making strong progress with 90% of rooms already sold

Unite Group plc (LON:UTG) Unite Students, the UK’s leading owner, manager and developer of student accommodation, today announces an update on current trading and quarterly property..

Enteq Technologies sells XXT for up to £3.2m

Enteq Technologies plc (LON:NTQ) the energy services technology and equipment supplier, has announced the sale of the XXT MWD (measurement while drilling) intellectual property and the..

Cambridge Cognition awarded two contracts worth £2.1 million for rare disease trials

Cambridge Cognition (LON:COG), which develops and markets digital solutions to assess brain health, has announced that it has won two sizeable contracts, together worth over £2.1..

Poolbeg Pharma a year of substantial progress

Poolbeg Pharma Plc (LON:POLB, OTCQB: POLBF), a leading biopharmaceutical company focusing on infectious and prevalent diseases with a high unmet medical need, has confirmed that the..

Search

Funds

April 12, 2023

Search

Funds

April 12, 2023

FTSE 100

Funds